{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:27:51Z","timestamp":1792168071044,"version":"4.4.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Human prion disease (PrD), a group of fatal and transmissible neurodegenerative diseases, consists of Creutzfeldt\u2013Jakob disease (CJD), kuru, fatal familial insomnia (FFI), Gerstmann-Str\u00e4ussler-Scheinker disease (GSS), and variably protease-sensitive prionopathy (VPSPr). The emergence of bovine spongiform encephalopathy (BSE) in cattle and variant CJD (vCJD) has greatly threatened public health, both in humans and animals. Since the 1990's, dozens of countries and territories have conducted PrD surveillance programs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the case numbers and alternative trends of different types of PrD globally and in various countries or territories from 1993 to 2020 were collected and analyzed based on the data from the websites of the international and national PrD surveillance programs, as well as from relevant publications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The total numbers of the reported PrD and sporadic CJD (sCJD) cases in 34 countries with accessible annual case numbers were 27,872 and 24,623, respectively. The top seven countries in PrD cases were the USA (<jats:italic>n<\/jats:italic> = 5,156), France (<jats:italic>n<\/jats:italic> = 3,276), Germany (<jats:italic>n<\/jats:italic> = 3,212), Italy (<jats:italic>n<\/jats:italic> = 2,995), China (<jats:italic>n<\/jats:italic> = 2,662), the UK (<jats:italic>n<\/jats:italic> = 2,521), Spain (<jats:italic>n<\/jats:italic> = 1,657), and Canada (<jats:italic>n<\/jats:italic> = 1,311). The annual PrD case numbers and mortalities, either globally or in the countries, showed an increased trend in the past 27 years. Genetic PrD cases accounted for 10.83% of all reported PrD cases; however, the trend varied largely among the different countries and territories. There have been 485 iatrogenic CJD (iCJD) cases and 232 vCJD cases reported worldwide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The majority of the countries with PrD surveillance programs were high- and upper-middle-income countries. However, most low- and lower-middle-income countries in the world did not conduct PrD surveillance or even report PrD cases, indicating that the number of human PrD cases worldwide is markedly undervalued. Active international PrD surveillance for both humans and animals is still vital to eliminate the threat of prion disease from a public health perspective.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1411489","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T04:24:57Z","timestamp":1718252697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Updated global epidemiology atlas of human prion diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Li-Ping","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Lin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Dong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"B1","unstructured":"PrizeTN\n          The Nobel Prize in Physiology or Medicine 19971997"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40249-016-0143-8","article-title":"Epidemiological characteristics of human prion diseases","volume":"5","author":"Chen","year":"2016","journal-title":"Infect Dis Pov."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","article-title":"Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation","volume":"20","author":"Uttley","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kov\u00e1cs","year":"2005","journal-title":"Hum Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3201\/eid2012.140548","article-title":"Transmission characteristics of variably protease-sensitive prionopathy","volume":"20","author":"Notari","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/pathogens2030457","article-title":"Prions in variably protease-sensitive prionopathy: an update","volume":"2","author":"Zou","year":"2013","journal-title":"Pathogens."},{"key":"B7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bmb\/66.1.185","article-title":"Bovine spongiform encephalopathy (BSE) and its epidemiology","volume":"66","author":"Smith","year":"2003","journal-title":"Br Med Bull."},{"key":"B8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet."},{"key":"B9","unstructured":"FoundationC\n          Creutzfeldt-Jakob Disease Foundation2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11040401","DOI":"10.3390\/pathogens11040401","article-title":"Chronic wasting disease monitoring in Italy 2017\u20132019","volume":"2022","author":"Tripodi","year":"2022","journal-title":"Neuropathol Find Cervids"},{"key":"B11","author":"Halldorsdottir","year":"2017","journal-title":"Chronic Wasting Disease in Norway"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1292\/jvms.12-0077","article-title":"Strain characterization of the Korean CWD cases in 2001 and 2004","volume":"75","author":"Lee","year":"2013","journal-title":"J Vet Med Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3201\/eid2406.172007","article-title":"Prion disease in dromedary camels Algeria","volume":"24","author":"Babelhadj","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B14","volume-title":"Global Surveillance, Diagnosis and Therapy of Human Transmissible Spongiform Encephalopathies: Report of a WHO Consultation.","year":"1998"},{"key":"B15","unstructured":"NetworkCJDIS\n          CJD Surveillance Data 1993\u201320202020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15509","DOI":"10.1038\/s41598-020-72519-0","article-title":"A nationwide trend analysis in the incidence and mortality of Creutzfeldt-Jakob disease in Japan between 2005 and 2014","volume":"10","author":"Nishimura","year":"2020","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3201\/eid2809.212050","article-title":"Creutzfeldt-Jakob disease incidence South Korea, 2001\u20132019","volume":"28","author":"Kim","year":"2022","journal-title":"Emerg Infect Dis."},{"key":"B18","unstructured":"WebsiteN\n          Projects2023"},{"key":"B19","year":"2023","journal-title":"Tables of Cases Examined in the USA"},{"key":"B20","year":"2021","journal-title":"Creutzfeldt-Jakob Disease Surveillance in the UK"},{"key":"B21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2188\/jea.17.133","article-title":"Creutzfeldt-Jakob disease mortality in Japan, 1979\u20132004: analysis of national death certificate data","volume":"17","author":"Doi","year":"2007","journal-title":"J Epidemiol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(59)90251-7","article-title":"Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea","volume":"26","author":"Gajdusek","year":"1959","journal-title":"Am J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","article-title":"Kuru in the 21st century\u2013an acquired human prion disease with very long incubation periods","volume":"367","author":"Collinge","year":"2006","journal-title":"Lancet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1098\/rstb.2008.0071","article-title":"Review. The epidemiology of Kuru: monitoring the epidemic from its peak to its end","volume":"363","author":"Alpers","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/vox.12371","article-title":"Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study","volume":"110","author":"Urwin","year":"2016","journal-title":"Vox Sang."},{"key":"B29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1212\/WNL.35.6.894","article-title":"High incidence of Creutzfeldt-Jakob disease in North African immigrants to France","volume":"35","author":"Cathala","year":"1985","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-3156.2005.01435.x","article-title":"Creutzfeldt-Jakob disease in Kenya","volume":"10","author":"Adam","year":"2005","journal-title":"Trop Med Int Health."},{"key":"B31","first-page":"289","article-title":"First case of presumed sporadic Creutzfeldt-Jakob disease in Marrakech Morocco","volume":"71","author":"Hajjaj","year":"2011","journal-title":"Med Trop."},{"key":"B32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41983-019-0085-8","article-title":"Probable Creutzfeldt-Jakob disease-a case report at Suez Canal University Hospital Egypt","volume":"55","author":"Mohamed Negm","year":"2019","journal-title":"Egypt J Neurol Psychiat Neurosurg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/IMCRJ.S287358","article-title":"Heidenhain variant of sporadic creutzfeldt-jakob disease: first reported case from East Africa","volume":"14","author":"Sokhi","year":"2021","journal-title":"Int Med Case Rep J."},{"key":"B34","first-page":"592","article-title":"A case of dura mater graft-associated Creutzfeldt-Jakob disease in South Africa","volume":"96","author":"Toovey","year":"2006","journal-title":"S Afr Med J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-510X(99)00179-3","article-title":"Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease","volume":"168","author":"Mouillet-Richard","year":"1999","journal-title":"J Neurol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/01.wnl.0000267642.41594.9d","article-title":"Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129","volume":"69","author":"Mead","year":"2007","journal-title":"Neurology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000110244","article-title":"Creutzfeldt-Jakob disease in India (1971-1990)","volume":"10","author":"Satishchandra","year":"1991","journal-title":"Neuroepidemiology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4103\/0972-2327.120486","article-title":"Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India","volume":"16","author":"Biswas","year":"2013","journal-title":"Ann Indian Acad Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/aian.AIAN_441_18","article-title":"Familial Creutzfeldt-Jakob disease: the first reported kindred from South-East Asia","volume":"22","author":"Sawal","year":"2019","journal-title":"Ann Indian Acad Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4103\/aian.AIAN_214_19","article-title":"Familial Creutzfeldt-Jakob disease in an Indian Kindred","volume":"22","author":"Katrak","year":"2019","journal-title":"Ann Indian Acad Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.47102\/annals-acadmedsg.V33N5p651","article-title":"Case reports of two biopsy-proven patients with Creutzfeldt-Jakob disease in Singapore","volume":"33","author":"See","year":"2004","journal-title":"Ann Acad Med Singap."},{"key":"B42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14802\/jmd.15014","article-title":"Creutzfeldt-Jakob disease in a tertiary care hospital in Thailand: a case series and review of the literature","volume":"8","author":"Lolekha","year":"2015","journal-title":"J Mov Disord."},{"key":"B43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0022-510X(96)00171-2","article-title":"Creutzfeldt-Jakob disease in Oman: report of two cases","volume":"142","author":"Scrimgeour","year":"1996","journal-title":"J Neurol Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.31436\/imjm.v22i3.2124","article-title":"A case series of RT-QuIC positive sporadic Creutzfeldt-Jakob disease-first two cases from Malaysia","volume":"3","author":"Muagan","year":"2023","journal-title":"IMJM."},{"key":"B45","doi-asserted-by":"publisher","first-page":"P03","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P03.260","article-title":"Epidemiology of Creutzfeldt-Jacob in Chile. Morbility and mortality","volume":"78","author":"Diaz","year":"2012","journal-title":"Neurol J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.24875\/RMN.20000099","article-title":"Clinical characteristics of Creutzfeldt-Jakob disease in Mexico: a retrospective analysis","volume":"21","author":"Chore\u00f1o-Parra","year":"2020","journal-title":"Rev Mex Neuroci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.24875\/GMM.M22000719","article-title":"Experience with Creutzfeldt-Jakob disease in a single referral center in Mexico","volume":"158","author":"C\u00e1rdenas-S\u00e1enz","year":"2022","journal-title":"Case series Gac Med Mex."},{"key":"B48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1590\/S1980-57642008DN10400004","article-title":"Prion diseases are undercompulsory notification in Brazil: surveillance of cases evaluated by biochemical and\/or genetic markers from 2005 to 2007","volume":"1","author":"Martins","year":"2007","journal-title":"Dement. Neuropsychol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.17843\/rpmesp.2014.312.60","article-title":"Creutzfeldt-Jakob disease in Peru: report of eleven cases","volume":"31","author":"Torres-Ramirez","year":"2014","journal-title":"Rev Peru Med Exp Salud Publica."},{"key":"B50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12883-018-1061-0","article-title":"Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito","volume":"18","author":"Torres Herran","year":"2018","journal-title":"BMC Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.186.4166.848.a","article-title":"Letter: Creutzfeldt-Jakob disease: hypothesis for high incidence in Libyan Jews in Israel","volume":"186","author":"Herzberg","year":"1974","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.41.9.1385","article-title":"The Libyan Creutzfeldt-Jakob disease focus in Israel: an epidemiologic evaluation","volume":"41","author":"Zilber","year":"1991","journal-title":"Neurology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00005792-199707000-00001","article-title":"Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews","volume":"76","author":"Meiner","year":"1997","journal-title":"Medicine."},{"key":"B54","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/ane.13684","article-title":"Genetic Creutzfeldt-Jakob disease in Turkish Jews-demographic and clinical features","volume":"146","author":"Menendez","year":"2022","journal-title":"Acta Neurol Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF00143120","article-title":"\u201cClusters\u201d of CJD in Slovakia: the first statistically significant temporo-spatial accumulations of rural cases","volume":"7","author":"Mitrova","year":"1991","journal-title":"Eur J Epidemiol."},{"key":"B56","first-page":"31","article-title":"Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development","volume":"46","author":"Mitrova","year":"2002","journal-title":"Acta Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.21101\/cejph.a5277","article-title":"Creutzfeldt-Jakob disease surveillance in Eastern Slovakia from 2004 to 2016","volume":"26","author":"Feketeova","year":"2018","journal-title":"Cent Eur J Public Health"},{"key":"B58","first-page":"279","article-title":"Creutzfeldt-Jakob disease in Hungary","volume":"43","author":"Kovacs","year":"2005","journal-title":"Folia Neuropathol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1093\/brain\/awq216","article-title":"Prospective 10-year surveillance of human prion diseases in Japan","volume":"133","author":"Nozaki","year":"2010","journal-title":"Brain."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1212\/01.WNL.0000160118.26865.11","article-title":"High incidence of genetic human transmissible spongiform encephalopathies in Italy","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology."},{"key":"B61","unstructured":""},{"key":"B62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","article-title":"The importance of ongoing international surveillance for Creutzfeldt-Jakob disease","volume":"17","author":"Watson","year":"2021","journal-title":"Nat Rev Neurol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1411489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T04:25:07Z","timestamp":1718252707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1411489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":62,"alternative-id":["10.3389\/fpubh.2024.1411489"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1411489","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"article-number":"1411489"}}